Previous Page  22 / 35 Next Page
Information
Show Menu
Previous Page 22 / 35 Next Page
Page Background

Routine molecular profiling is the only way to

identify all potential patients candidates to receive

targeted treatment

•

Large-scale molecular testing challenges

–

Quality

–

Reproducibility

–

Unrestricted access

–

Adequate turn-around time

•

Routine molecular profiling in France

(Barlessi F. et al, Lancet 2016)

–

Feasibility of the implementation of large-scale nationwide

decentralized testing,

–

Tests free of charge for patients and institutions.

–

Improvement in the survival of about 50% of patients

1